NASDAQ : OGI
Organigram Global Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Last price 0.9331 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 133.40M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 139.03M |
| Enterprise Value | 204.28M |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 15, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 141.01M |
| Shares Outstanding | 141.01M |
| Shares Change (YoY) | +21.14% |
| Shares Change (QoQ) | +3.77% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 3.85% |
| Float | 97.33M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 2.14 |
| Forward PE | 17.38 |
| PS Ratio | 0.61 |
| Forward PS | 0.41 |
| PB Ratio | 0.34 |
| P/TBV Ratio | 2.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 3.26 |
| EV / Sales | 0.91 |
| EV / EBITDA | 17.17 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.61 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 1.81 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 17.56% |
| Return on Assets (ROA) | -0.60% |
| Return on Invested Capital (ROIC) | -1.33% |
| Return on Capital Employed (ROCE) | -0.94% |
| Weighted Average Cost of Capital (WACC) | 12.65% |
| Revenue Per Employee | $194,387 |
| Profits Per Employee | $54,462 |
| Employee Count | 1,120 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 1.35 |
Taxes
| Measure | Value |
|---|
| Income Tax | -3.77M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -41.68% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 40.08 |
| Average Volume (20 Days) | 305,865 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.82M |
| Short Previous Month | 4.49M |
| Short % of Shares Out | 3.42% |
| Short % of Float | 4.95% |
| Short Ratio (days to cover) | 9.89 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 217.71M |
| Gross Profit | 79.56M |
| Operating Income | -4.71M |
| Pretax Income | 57.23M |
| Net Income | 61.00M |
| EBITDA | 11.57M |
| EBIT | -4.71M |
| Earnings Per Share (EPS) | $0.45 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 8.22M |
| Total Debt | 22.29M |
| Net Cash | -14.07M |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 391.89M |
| Book Value Per Share | 2.42 |
| Working Capital | 121.69M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -20.43M |
| Capital Expenditures | -810,052 |
| Depreciation & Amortization | 16.56M |
| Net Borrowing | 13.64M |
| Free Cash Flow | -21.24M |
| FCF Per Share | -$0.15 |
Margins
| Measure | Value |
|---|
| Gross Margin | 36.54% |
| Operating Margin | -2.16% |
| Pretax Margin | 26.29% |
| Profit Margin | 28.02% |
| EBITDA Margin | 5.31% |
| EBIT Margin | -2.16% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.14% |
| Shareholder Yield | -21.14% |
| Earnings Yield | 46.77% |
| FCF Yield | -15.92% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $2.44 |
| Price Target Difference | 150.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 23.36% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |